SOURCE: Reflect Scientific, Inc.

Reflect Scientific, Inc.

December 10, 2013 06:00 ET

Reflect Scientific, Inc. Receives Follow on Order for Cryometrix T-150 Freezer From Large Pharmaceutical Company

OREM, UT--(Marketwired - Dec 10, 2013) - Reflect Scientific, Inc. (OTCBB: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries announced a major pharmaceutical company has placed a follow on order for Cryometrix T-150 Ultra Low Temperature (ULT) Freezers.

A major pharmaceutical company has placed an additional order for the Cryometrix T-150 ULT Freezer and anticipates further orders in 2014. Boyd Bowdish, Principal Scientist at Reflect Scientific, commented, "The T-150 has performed beyond expectations and has become an integral part of their manufacturing process. Confidence in the Cryometrix product and its performance has allowed them to expand its use to other processes."

The Cryometrix T-150 ULT Freezer offers advantages of uniform temperature, low maintenance and very low power consumption.

About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific's products are low temperature freezers and refrigerated systems for laboratory, transportation and computer server room uses. For more information, visit www.reflectscientific.com.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.

Contact Information

  • Contact:

    Thomas Tait
    Vice President
    719-357-5878